Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1993 Nov;48(11):1125–1129. doi: 10.1136/thx.48.11.1125

Distribution of immunocompetent cells in the bronchial wall of clinically healthy subjects showing bronchial hyperresponsiveness.

C Power 1, S Sreenan 1, B Hurson 1, C Burke 1, L W Poulter 1
PMCID: PMC464896  PMID: 8296256

Abstract

BACKGROUND--Nearly all asthmatic subjects show bronchial hyperresponsiveness, in that the provocative concentration of histamine reducing forced expiratory volume in one second (FEV1) by 20% (PC20FEV1) is < or = 8 mg/ml histamine, and have underlying chronic inflammation of the bronchial wall mediated by T cells. The possible cause and effect relationship between these phenomena remains an enigma. As a proportion of clinically healthy subjects show bronchial hyperresponsiveness, this study was undertaken to determine whether they also show evidence of bronchial inflammation. METHODS--Bronchial biopsy specimens were obtained from 27 clinically healthy subjects with no history of lung disease. Samples were taken perioperatively before elective knee arthroscopy for sports injuries. Specimens were frozen and cryostat sections analysed immunocytochemically with monoclonal antibodies to identify the presence of T lymphocytes, antigen presenting cells, and the expression of HLA-DR. Double immunofluorescence studies were performed with monoclonal antibodies RFD1 and RFD7 to show the relative proportions of RFD1+ RFD7- antigen presenting cells, RFD1- RFD7+ mature phagocytes, and RFD1+ RFD7+ suppressor macrophages. Histological stains were performed to show the presence of eosinophils and mast cells. Three to four weeks after bronchoscopy spirometry was performed on these subjects to record FEV1, forced vital capacity (FVC), FEV1/FVC, and forced expiratory flow between 25% and 75% of vital capacity (FEF25-75). Bronchial hyperreactivity was recorded by determining PC20FEV1 to histamine. RESULTS--Nine of the 27 subjects showed bronchial hyperresponsiveness as defined by a PC20FEV1 of < or = 8 mg/ml histamine. Segregated subjects with and without bronchial hyperresponsiveness showed no difference in spirometric results. Immunohistological analysis showed no evidence of inflammation in either group. Numbers of T cells, eosinophils, and mast cells were the same in both groups as was the expression of HLA-DR antigen. No neutrophils were observed in any tissues. Interestingly, reduced numbers of macrophages with the phenotype of antigen presenting cells (monoclonal antibodies RFD1+ RFD7-) were recorded in the subjects with bronchial hyperresponsiveness, who also had a significant increase in the proportion of RFD1+ RFD7+ suppressor macrophages. CONCLUSIONS--Up to 30% of selected clinically healthy subjects may have a PC20FEV1 of < or = 8 mg/ml histamine. This physiological trait can exist in the absence of bronchial inflammation. This suggests that bronchial hyperresponsiveness as currently defined is not dependent on immunopathological changes in the bronchial wall and does not necessarily promote even subclinical inflammation.

Full text

PDF
1125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boushey H. A., Holtzman M. J., Sheller J. R., Nadel J. A. Bronchial hyperreactivity. Am Rev Respir Dis. 1980 Feb;121(2):389–413. doi: 10.1164/arrd.1980.121.2.389. [DOI] [PubMed] [Google Scholar]
  2. Burke C., Power C. K., Norris A., Condez A., Schmekel B., Poulter L. W. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J. 1992 Jan;5(1):73–79. [PubMed] [Google Scholar]
  3. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  4. Gause W. C., Mountz J. D., Steinberg A. D. Characterization and differentiation of CD4-, CD8- thymocytes sorted with the Ly-24 marker. J Immunol. 1988 Jan 1;140(1):1–7. [PubMed] [Google Scholar]
  5. Hargreave F. E., Ryan G., Thomson N. C., O'Byrne P. M., Latimer K., Juniper E. F., Dolovich J. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol. 1981 Nov;68(5):347–355. doi: 10.1016/0091-6749(81)90132-9. [DOI] [PubMed] [Google Scholar]
  6. Hutter C., Poulter L. W. The balance of macrophage subsets may be customised at mucosal surfaces. FEMS Microbiol Immunol. 1992 Dec;5(5-6):309–315. doi: 10.1111/j.1574-6968.1992.tb05915.x. [DOI] [PubMed] [Google Scholar]
  7. Poulter L. W., Campbell D. A., Munro C., Janossy G. Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies. Scand J Immunol. 1986 Sep;24(3):351–357. doi: 10.1111/j.1365-3083.1986.tb02104.x. [DOI] [PubMed] [Google Scholar]
  8. Poulter L. W., Norris A., Power C., Condez A., Burnes H., Schmekel B., Burke C. T cell dominated inflammatory reactions in the bronchioles of asymptomatic asthmatics are also present in the nasal mucosa. Postgrad Med J. 1991 Aug;67(790):747–753. doi: 10.1136/pgmj.67.790.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Poulter L. W., Power C., Burke C. The relationship between bronchial immunopathology and hyperresponsiveness in asthma. Eur Respir J. 1990 Jul;3(7):792–799. [PubMed] [Google Scholar]
  10. Silva J. R., Jones J. A., Cole P. J., Poulter L. W. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax. 1989 Aug;44(8):668–673. doi: 10.1136/thx.44.8.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wardlaw A. J., Dunnette S., Gleich G. J., Collins J. V., Kay A. B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis. 1988 Jan;137(1):62–69. doi: 10.1164/ajrccm/137.1.62. [DOI] [PubMed] [Google Scholar]
  12. Whyte M. K., Choudry N. B., Ind P. W. Bronchial hyperresponsiveness in patients recovering from acute severe asthma. Respir Med. 1993 Jan;87(1):29–35. doi: 10.1016/s0954-6111(05)80310-5. [DOI] [PubMed] [Google Scholar]
  13. Woolcock A. J., Yan K., Salome C. M. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin Allergy. 1988 Mar;18(2):165–176. doi: 10.1111/j.1365-2222.1988.tb02856.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES